HomeBusinessHealthcare Industry Stock NewsSpyre (SYRE) CEO On IBD Market Growth
00:00
00:00
07:33
Spyre (SYRE) CEO On IBD Market Growth

Spyre (SYRE) CEO On IBD Market Growth

Spyre (SYRE) is a biotech company that aims to create the next-generation of inflammatory bowel disease products. CEO Cameron Tuttle joins Oliver Renick to discuss the company as it began trading on the NASDAQ following an acquisition of Aeglea. Tuttle talks about how the IBD market is expected to grow to $29B by 2028, as the CDC estimates that 3.1M Americans have been diagnosed with IBD. Tune in to find out more about the stock market today.

Morning Trade Live

06 Dec 2023

SHARE

ON AIR
2:00 pm
Morning Trade Live
6:00 am
Gamma On
REPLAY
6:30 am
Gamma On
REPLAY
7:00 am
Gamma On
REPLAY
7:30 am
Gamma On
REPLAY
8:30 am
Gamma On
REPLAY
9:00 am
Gamma On
REPLAY
9:30 am
Gamma On
REPLAY
10:00 am
Gamma On
REPLAY
11:00 am
Gamma On
REPLAY
12:00 pm
Gamma On
REPLAY
1:00 pm
Morning Movers
ON AIR
2:00 pm
Morning Trade Live
4:00 pm
Trading 360
5:00 pm
Fast Market
6:00 pm
Next Gen Investing
7:00 pm
The Watch List
8:00 pm
Market On Close
9:30 pm
Market Overtime
REPLAY
10:00 pm
Trading 360
REPLAY
11:00 pm
Fast Market
REPLAY
12:00 am
Next Gen Investing
REPLAY
1:00 am
Gamma On
REPLAY
2:00 am
Market Overtime
REPLAY
2:30 am
Market Overtime
REPLAY
3:00 am
Gamma On
REPLAY
education
4:00 am
Inside the Mind of a Trader
REPLAY
education
4:30 am
Inside the Mind of a Trader
REPLAY
education
5:00 am
Inside the Mind of a Trader
REPLAY
education
5:30 am
Your First Trade
REPLAY

Get the Market Minute

Daily insights for every investor